Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells
- PMID: 7547504
Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells
Abstract
The transforming growth factor-beta (TGF-beta) superfamily is a group of secreted growth factors that appears to play a central role in mesenchymal differentiation, including cartilage and bone formation. The present study examines the role of one member of this family, vgr-1, also called bone morphogenetic protein-6, in mesenchymal cell differentiation. This factor may be considered as a prototype for the largest subgroup of related factors within the TGF-beta superfamily, the function of which has as yet been poorly defined. vgr-1 has been localized previously to hypertrophic cartilage and has been shown to induce endochondral bone formation in vivo. To further characterize the role of vgr-1 in bone and cartilage differentiation, we stably transfected the pluripotent mesenchymal cell line ROB-C26 with a vector to overexpress vgr-1. Overexpression of this factor did not affect cell shape or morphology, but it enhanced osteoblastic differentiation in vitro and altered cellular responsiveness to retinoic acid. Furthermore, the extracellular matrix produced by these vgr-1-overexpressing cells induced ectopic bone formation in vivo and osteoblastic differentiation in vitro, similar to the matrix produced by C26 cells treated with retinoic acid. The osteoinductive effect of the matrix from vgr-1-overexpressing cells was blocked using a neutralizing vgr-1 antibody but not with a neutralizing TGF-beta 1 antibody, indicating that vgr-1 alone was required for this osteogenic effect. In contrast, the osteoinductive effect of matrix from retinoic acid-treated cells was blocked with both vgr-1 and TGF-beta 1 antibodies, suggesting that TGF-beta 1 may act prior to vgr-1 during osteoblastic differentiation. We further demonstrated that osteoinduction by vgr-1 was dependent on presentation of vgr-1 within the matrix, because the osteoinductive effect of matrix from vgr-1-overexpressing cells could not be mimicked with the addition of soluble vgr-1 to parental C26 cells. Finally, overexpression of MyoD within the C26 cells overexpressing vgr-1 converted the cells to myoblasts, indicating that vgr-1 had induced early osteoblastic.
Similar articles
-
The role of type I collagen in the regulation of the osteoblast phenotype.J Bone Miner Res. 1996 Aug;11(8):1139-45. doi: 10.1002/jbmr.5650110813. J Bone Miner Res. 1996. PMID: 8854250
-
Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells.Mol Endocrinol. 1993 Feb;7(2):189-98. doi: 10.1210/mend.7.2.8385738. Mol Endocrinol. 1993. PMID: 8385738
-
Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta 1 in osteoblast cell-matrix interaction.J Bone Miner Res. 1995 Aug;10(8):1203-8. doi: 10.1002/jbmr.5650100810. J Bone Miner Res. 1995. PMID: 8585424
-
Ets transcription factors and targets in osteogenesis.Oncogene. 2000 Dec 18;19(55):6455-63. doi: 10.1038/sj.onc.1204037. Oncogene. 2000. PMID: 11175361 Review.
-
Role of transforming growth factor-beta in bone remodeling.Clin Orthop Relat Res. 1990 Jan;(250):261-76. Clin Orthop Relat Res. 1990. PMID: 2403492 Review.
Cited by
-
Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen.J Clin Invest. 1998 Jan 15;101(2):413-22. doi: 10.1172/JCI119880. J Clin Invest. 1998. PMID: 9435314 Free PMC article.
-
Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.J Cell Biol. 1996 Oct;135(1):227-39. doi: 10.1083/jcb.135.1.227. J Cell Biol. 1996. PMID: 8858176 Free PMC article.
-
Phosphatidylethanolamine biomimetic coating increases mesenchymal stem cell osteoblastogenesis.J Mater Sci Mater Med. 2014 Nov;25(11):2561-71. doi: 10.1007/s10856-014-5263-8. Epub 2014 Jul 1. J Mater Sci Mater Med. 2014. PMID: 24980874
-
Starch-poly-epsilon-caprolactone microparticles reduce the needed amount of BMP-2.Clin Orthop Relat Res. 2009 Dec;467(12):3138-48. doi: 10.1007/s11999-009-0954-z. Epub 2009 Jun 26. Clin Orthop Relat Res. 2009. PMID: 19557487 Free PMC article.
-
Quinoline compound KM11073 enhances BMP-2-dependent osteogenic differentiation of C2C12 cells via activation of p38 signaling and exhibits in vivo bone forming activity.PLoS One. 2015 Mar 19;10(3):e0120150. doi: 10.1371/journal.pone.0120150. eCollection 2015. PLoS One. 2015. PMID: 25789987 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases